FDA boosts transparency to 77%

The FDA's mighty efforts to become a more transparent government agency, beginning with a transparency task force, convened in June, are yielding results, says blogger Mark Senak. His transparency metric of advisory committee rosters that include links to committee member CVs has seen a rise to 77 percent, up from 50 percent. Blog

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.